Dr Reddy's inks licensing pact with Eli Lilly for COVID-19 treatment drug

PTIUpdated: Tuesday, May 11, 2021, 11:00 PM IST
article-image
Health workers wearing personal protective equipment (PPE kit) attend to Covid-19 coronavirus patients inside a banquet hall temporarily converted into a Covid care centre in New Delhi on May 7, 2021/ File | (Photo by AFP)

Dr Reddy's Laboratories on Tuesday said it has inked a licensing pact with Eli Lilly and Company to produce Baricitinib in the country for treatment of COVID-19.

The Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialisation of the drug in India.

Baricitinib has received restricted emergency use approval from the Central Drugs Standard Control Organisation (CDSCO) for use in combination with remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalised adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

This partnership comes at a critical juncture in the fight against the pandemic in India, and adds to the company's existing range of COVID-19 therapeutics covering the full spectrum from mild to moderate and severe conditions of the disease, and a vaccine, Dr Reddy's noted.

"From the start, we have been determined to explore every possible avenue against COVID-19. Our collaboration with Lilly will help us make yet another treatment option available to patients in India," Dr Reddy's Laboratories CEO (API and Services) Deepak Sapra said.

On May 10, Eli Lilly and Company had announced voluntary licensing agreements with Sun Pharma, Cipla and Lupin to expedite the availability of its arthritis drug Baricitinib for treatment of COVID-19 patients in India.

(To receive our E-paper on whatsapp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Daily Horoscope for Saturday, August 20, 2022, for all zodiac signs by astrologer Vinayak Vishwas...

Daily Horoscope for Saturday, August 20, 2022, for all zodiac signs by astrologer Vinayak Vishwas...

Mumbai: CGST busts fake invoice rackets

Mumbai: CGST busts fake invoice rackets

2006 Mumbai train blasts: ATS calls convict’s plea for reinvestigation ‘dilatory tactic’

2006 Mumbai train blasts: ATS calls convict’s plea for reinvestigation ‘dilatory tactic’

Mumbai: Record or no record, it is the high that matters, say Govindas

Mumbai: Record or no record, it is the high that matters, say Govindas

Mumbai: After 2-year gap, Dahi Handi reaches 'heights' of festivity

Mumbai: After 2-year gap, Dahi Handi reaches 'heights' of festivity